Literature DB >> 25162689

Outpatient management of young febrile infants with urinary tract infections.

David Schnadower1, Nathan Kuppermann, Charles G Macias, Stephen B Freedman, Dewesh Agrawal, Jingnan Mao, Peter S Dayan.   

Abstract

OBJECTIVE: Controversy exists regarding the disposition of young febrile infants who present to emergency departments (EDs) with urinary tract infections (UTIs). In a large multicenter cohort of such patients, we aimed to determine the variation in patient disposition and clinical factors independently associated with outpatient management.
METHODS: Secondary analysis of a retrospective study of infants 29 to 60 days with fever (≥38.0°C), urinalysis finding, and culture-proven UTIs presenting to 20 North American EDs belonging to the Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics. We determined independent factors associated with outpatient management.
RESULTS: Of 1764 infants with UTIs, 132 (7.5%) were discharged home from the ED. The proportion of infants managed as outpatients varied among sites (0%-20.0%). Of the 132 infants, 29 (22.0%) were subsequently hospitalized after culture results were known, including 5 patients with bacteremia. None of the 107 patients initially discharged from the ED for whom outcomes were known had adverse events (0%; 95% CI, 0%-2.7%). On multivariable regression and generalized estimated equations analyses, only clinical site, presence of upper respiratory tract infection symptoms, absence of vomiting, and having fewer than 10 white blood cells per microliter on cerebrospinal fluid examination were independently associated with discharge from the ED. Clinical site was the factor most highly associated with outpatient management (odds ratio, 8.8; 95% confidence interval, 5.2-15.0).
CONCLUSIONS: There is substantial practice variation regarding the disposition of febrile infants 29 to 60 days of age with UTIs. Institutional practice is the strongest predictor of outpatient management. Further evidence is needed to guide the management of non-toxic-appearing young febrile infants with UTIs.

Entities:  

Mesh:

Year:  2014        PMID: 25162689     DOI: 10.1097/PEC.0000000000000202

Source DB:  PubMed          Journal:  Pediatr Emerg Care        ISSN: 0749-5161            Impact factor:   1.454


  4 in total

1.  Predicting Hemolytic Uremic Syndrome and Renal Replacement Therapy in Shiga Toxin-producing Escherichia coli-infected Children.

Authors:  Ryan S McKee; David Schnadower; Phillip I Tarr; Jianling Xie; Yaron Finkelstein; Neil Desai; Roni D Lane; Kelly R Bergmann; Ron L Kaplan; Selena Hariharan; Andrea T Cruz; Daniel M Cohen; Andrew Dixon; Sriram Ramgopal; Annie Rominger; Elizabeth C Powell; Jennifer Kilgar; Kenneth A Michelson; Darcy Beer; Martin Bitzan; Christopher M Pruitt; Kenneth Yen; Garth D Meckler; Amy C Plint; Stuart Bradin; Thomas J Abramo; Serge Gouin; April J Kam; Abigail Schuh; Fran Balamuth; Tracy E Hunley; John T Kanegaye; Nicholas E Jones; Usha Avva; Robert Porter; Daniel M Fein; Jeffrey P Louie; Stephen B Freedman
Journal:  Clin Infect Dis       Date:  2020-04-10       Impact factor: 9.079

2.  Febrile Infants ≤60 Days Old With Positive Urinalysis Results and Invasive Bacterial Infections.

Authors:  Lyubina C Yankova; Mark I Neuman; Marie E Wang; Christopher Woll; Adrienne G DePorre; Sanyukta Desai; Laura F Sartori; Lise E Nigrovic; Christopher M Pruitt; Richard D Marble; Rianna C Leazer; Sahar N Rooholamini; Fran Balamuth; Paul L Aronson
Journal:  Hosp Pediatr       Date:  2020-12

3.  Transition to oral antibiotic therapy for pyelonephritis in children under 60 days of age: An observational retrospective cohort study.

Authors:  David-Alexandre Lessard; Thelma Huard-Girard; Arnaud Tremblay; Jean-Francois Turcotte
Journal:  Paediatr Child Health       Date:  2020-01-09       Impact factor: 2.253

4.  Hypothermia in Young Infants: Frequency and Yield of Sepsis Workup.

Authors:  Michelle C Perry; Susan K Yaeger; Katie Noorbakhsh; Andrea T Cruz; Robert W Hickey
Journal:  Pediatr Emerg Care       Date:  2021-08-01       Impact factor: 1.602

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.